학술논문

Phase I evaluation of telatinib, a VEGF receptor tyrosine kinase inhibitor, in combination with bevacizumab in subjects with advanced solid tumors
Document Type
Article
Source
In Annals of Oncology November 2011 22(11):2508-2515
Subject
Language
ISSN
0923-7534